C1q, antibodies and anti-C1q autoantibodies
- PMID: 26032012
- DOI: 10.1016/j.molimm.2015.05.010
C1q, antibodies and anti-C1q autoantibodies
Abstract
The complement system has long been known for its role in combating infections. More recently the complement system is becoming increasingly appreciated for its role in processes that range from waste transport, immune tolerance and shaping of the adaptive immune response. Antibodies represent the humoral part of the adaptive immune response and the complement system interacts with antibodies in several ways. Activated complement fragments impact on the production of antibodies, the complement system gets activated by antibodies and complement proteins can be the target of (auto)antibodies. In this review, written to celebrate the contributions of Prof. Dr. M.R. Daha to the field of immunology and especially complement, we will focus on C1q and its various interactions with antibodies. We will specifically focus on the mechanisms by which C1q will interact with monomeric IgG versus polymerized IgG and fluid-phase IgM versus solid-phase IgM. In addition in this review we will discuss in detail how C1q itself is targeted by autoantibodies and how these autoantibodies are currently considered to play a role in human disease.
Keywords: Antibodies; C1q; Complement.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2310666120. doi: 10.1073/pnas.2310666120. Epub 2023 Dec 4. Proc Natl Acad Sci U S A. 2023. PMID: 38048459 Free PMC article.
-
C1q: a multifunctional ligand for a new immunoadsorption treatment.Ther Apher. 1999 Aug;3(3):246-51. doi: 10.1111/j.1091-6660.1999.t01-2-.x. Ther Apher. 1999. PMID: 10427623
-
New insight into the autoimmunogenicity of the complement protein C1q.Mol Immunol. 2011 Jan;48(4):678-82. doi: 10.1016/j.molimm.2010.11.010. Epub 2010 Dec 14. Mol Immunol. 2011. PMID: 21159384
-
C1q and systemic lupus erythematosus.Immunobiology. 1998 Aug;199(2):265-85. doi: 10.1016/S0171-2985(98)80032-6. Immunobiology. 1998. PMID: 9777411 Review.
-
Anti-C1q autoantibodies.Autoimmun Rev. 2008 Sep;7(8):612-5. doi: 10.1016/j.autrev.2008.06.006. Epub 2008 Jul 9. Autoimmun Rev. 2008. PMID: 18606253 Review.
Cited by
-
Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.Pediatr Nephrol. 2017 Sep;32(9):1537-1545. doi: 10.1007/s00467-017-3646-z. Epub 2017 Mar 25. Pediatr Nephrol. 2017. PMID: 28343355
-
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseases.Immunobiology. 2025 May;230(3):152915. doi: 10.1016/j.imbio.2025.152915. Epub 2025 May 20. Immunobiology. 2025. PMID: 40409177 Free PMC article. Review.
-
Production of complement components by cells of the immune system.Clin Exp Immunol. 2017 May;188(2):183-194. doi: 10.1111/cei.12952. Epub 2017 Mar 24. Clin Exp Immunol. 2017. PMID: 28249350 Free PMC article. Review.
-
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2310666120. doi: 10.1073/pnas.2310666120. Epub 2023 Dec 4. Proc Natl Acad Sci U S A. 2023. PMID: 38048459 Free PMC article.
-
Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies.Lupus Sci Med. 2021 Oct;8(1):e000531. doi: 10.1136/lupus-2021-000531. Lupus Sci Med. 2021. PMID: 34725184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical